Search Results for keywords:"Health and Human Services"

The National Institutes of Health (NIH) will hold a meeting of the HEAL Multi-Disciplinary Working Group to discuss the Helping to End Addiction Long-term Initiative on March 2-3, 2021. The meeting will be partially open to the public and will be webcast live, with sessions closed to protect confidential information. Interested individuals can contact Rebecca G. Baker, Ph.D. for further information or to submit comments. Details and agendas will be available on the NIH HEAL Initiative's website.

The National Institute of Nursing Research has announced a change to the timing of their Special Emphasis Panel meeting. Originally scheduled from 10:00 a.m. to 2:00 p.m. on February 19, 2021, the meeting will now be held from 2:00 p.m. to 4:00 p.m. The meeting is not open to the public and will take place at Democracy One in Bethesda, Maryland.

The Food and Drug Administration (FDA) has announced a list of information collections that have recently received approval from the Office of Management and Budget (OMB), under the Paperwork Reduction Act of 1995. Each collection of information has a specific OMB control number and an expiration date for its approval. The FDA emphasizes that any information collection they conduct must display a valid OMB control number; otherwise, individuals are not required to respond to it. More details, including the supporting statements for these collections, can be found online.

The National Institute on Aging has announced a change to the date of an upcoming meeting. Originally scheduled for March 1, 2021, the meeting will now be held on March 15, 2021. This meeting will take place at the Gateway Building in Bethesda, Maryland and is not open to the general public. This change was officially noted in the Federal Register on February 4, 2021.

The Advanced Research Projects Agency for Health (ARPA-H) within the Department of Health and Human Services is updating its structure to better meet legal requirements. This new organization includes various offices that focus on expanding health technology, improving healthcare access, and driving innovation in health systems. Each office has specific roles, such as developing new tools, improving health system resilience, and increasing healthcare accessibility. The Secretary of Health and Human Services, Xavier Becerra, has endorsed these changes to ensure ARPA-H effectively supports health advancements.

The Office of Minority Health announced the cancellation of a meeting for the Advisory Committee on Minority Health that was scheduled for January 7, 2025. This cancellation was initially announced in the Federal Register on December 9, 2024. For more information, individuals can contact Violet Woo, the Designated Federal Officer, via telephone or email.

The Food and Drug Administration (FDA) is inviting public comments on a proposed rule regarding the labeling of natural rubber latex condoms. This action is part of the requirements under the Paperwork Reduction Act, which mandates federal agencies to gather public input on collections of information. The FDA's proposal aims to review and potentially update the labeling of condoms to ensure it accurately reflects their effectiveness in preventing sexually transmitted diseases. Interested parties can submit their comments electronically or by mail by March 5, 2021.

The Department of Health and Human Services and the Food and Drug Administration (FDA) are proposing to permanently waive certain premarket notification requirements for specific medical devices. This action follows temporary waivers provided during the COVID-19 pandemic to make medical devices more accessible. The proposal includes making seven class I devices and 84 class II devices permanently exempt from the 510(k) premarket notification requirement, which typically involves a costly and time-consuming process. The public is invited to comment on the proposed exemptions and suggest improvements to the regulatory system concerning medical devices.